يعرض 1 - 10 نتائج من 920 نتيجة بحث عن '"Wang Yucai"', وقت الاستعلام: 1.69s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المؤلفون: Qi, Xinyue (ORCID 0000-0002-3954-0974), Zhou, Shouhao (ORCID 0000-0002-8124-5047), Wang, Yucai (ORCID 0000-0002-1576-8341), Peterson, Christine (ORCID 0000-0003-3316-0468)

    المصدر: Research Synthesis Methods. Nov 2022 13(6):807-820.

    تمت مراجعته من قبل الزملاء: Y

    Page Count: 14

    Sponsoring Agency: National Cancer Institute (NCI) (DHHS/NIH)

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Rejeski K Department of Medicine III – Hematology/Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK), Munich and Berlin Sites, and German Cancer Research Center, Heidelberg, Germany. Adult BMT and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY. Wang Y, Bansal R Division of Hematology, Mayo Clinic, Rochester, MN. Hansen DK Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL. Iacoboni G, Barba P Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Bachy E Department of Hematology, Lyon Sud Hospital, INSERM 1052, Pierre-Bénite, France, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Blood Advances;8(8); https://doi.org/10.1182/bloodadvances.2023011767Test; Rejeski K, Wang Y, Hansen DK, Iacoboni G, Bachy E, Bansal R, et al. Applying the EHA/EBMT Grading for ICAHT after CAR-T: Comparative Incidence and Association with Infections and Mortality. Blood Adv. 2024 Apr 23;8(8):1857–1868.; https://hdl.handle.net/11351/11330Test

  4. 4
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    تقرير
  8. 8
    دورية أكاديمية

    المساهمون: Wang, Michael L., Jurczak, Wojciech, Zinzani, Pier Luigi, Eyre, Toby A., Cheah, Chan Y., Ujjani, Chaitra S., Koh, Youngil, Izutsu, Koji, Gerson, James N., Flinn, Ian, Tessoulin, Benoit, Alencar, Alvaro J., Ma, Shuo, Lewis, David, Lech-Maranda, Ewa, Rhodes, Joanna, Patel, Krish, Maddocks, Kami, Lamanna, Nicole, Wang, Yucai, Tam, Constantine S., Munir, Talha, Nagai, Hirokazu, Hernandez-Ilizaliturri, Francisco, Kumar, Anita, Fenske, Timothy S., Seymour, John F., Zelenetz, Andrew D., Nair, Binoj, Tsai, Donald E., Balbas, Minna, Walgren, Richard A., Abada, Paolo, Wang, Chunxiao, Zhao, Junjie, Mato, Anthony R., Shah, Nirav N.

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37192437; info:eu-repo/semantics/altIdentifier/wos/WOS:001058339300006; volume:41; issue:24; firstpage:3988; lastpage:3997; numberofpages:10; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11585/960656Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85166977934

  9. 9
    مؤتمر

    المصدر: Wang , Y , Larson , M C , Farooq , U , Ekberg , S , Smedby , K E , Simonsen , M R , Niemann , C U , Zhao , E J , Gerrie , A S , Switchenko , J M , Bond , D A , Bachanova , V , Barta , S K , Hill , B T , Martin , P , Danilov , A V , Grover , N S , Karmali , R , Ghosh , N , Fenske , T S , Kahl , B S , Albertsson-Lindblad ....

  10. 10
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Rejeski K Department of Medicine III – Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany. Wang Y Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA. Albanyan O Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida, USA. Munoz J Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA. Sesques P Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, Pierre-Bénite, France. Iacoboni G Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Department of Medicine, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: American Journal of Hematology;98(11); https://doi.org/10.1002/ajh.27056Test; Rejeski K, Wang Y, Albanyan O, Munoz J, Sesques P, Iacoboni G, et al. The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL. Am J Hematol. 2023 Nov;98(11):1699–710.; https://hdl.handle.net/11351/10464Test; 001051772500001